ASTORIA, N.Y., Jan. 5, 2022 /PRNewswire-PRWeb/ -- Spectrum
Vision Partners, ("SVP"), is pleased to announce that they have
entered into an Agreement with The Mackool Eye Institute and Laser
Center (MEI). Since 1978, Mackool Eye Institute has been on the
cutting edge of cataract, glaucoma and cornea procedures, providing
comprehensive eye care and surgical services to patients from
New York, the surrounding states
and indeed from around the world in Astoria, New York. Joining SVP's supported
practice in New York, OCLI Vision,
are Richard J. Mackool, MD and R.J.
Mackool, MD. OCLI Vision also welcomes Drs. Vivian Monsanto and Marc
Sirota to the team.
SVP serves many of the top ophthalmology groups and ambulatory
eye surgery centers in New York,
New Jersey, Connecticut, and Pennsylvania. Mackool Eye Institute is
Spectrum's 19th affiliation since 2017.
Tom Burke, SVP's CEO, said,
"Spectrum Vision Partners is thrilled to announce the addition of
Drs. Richard and R.J. Mackool and
their entire Mackool Eye Institute team to our growing company. The
level of expertise and experience displayed by the surgeons at
Mackool Eye Institute is inspiring and humbling. We could not be
more excited to work alongside them, learn from them and
collaborate on new technology and innovations to improve patient
care. They are truly at the forefront of ophthalmology and have led
the way with significant efforts to improve their patients' eye
health, first and foremost. We are very proud to call them partners
and to be at their service. We are really looking forward to what
we can build together."
Richard J. Mackool, M.D. is the
founder and Director of the Mackool Eye Institute, which was the
first eye care center in New York
to provide eye surgery and laser treatment without the need for
hospitalization. He is an internationally recognized expert on eye
microsurgery and has maintained his practice in ophthalmology since
1973. He is a professor of ophthalmic surgery at the New York Eye
and Ear Infirmary and NYU Medical Center. An inventor of
computerized microsurgical instruments and techniques for cataract
removal, nearsightedness, and astigmatism, Dr. Mackool has
published many scientific papers and textbooks and has been granted
more than 100 patents. He has lectured throughout the United States and abroad, and eye surgeons
from every continent have traveled to New
York to attend courses conducted by Dr. Mackool.
Dr. R.J. Mackool is the Assistant Director of the Mackool Eye
Institute. He has extensive experience in cataract, implant,
glaucoma, and corneal surgery. Additionally, he completed training
in general surgery, plastic surgery, and craniofacial surgery prior
to ophthalmology training at the New York Eye and Ear Infirmary of
Mount Sinai.
Dr. Mackool has designed microsurgical instruments and he has
several medical patents pending for devices that improve the
accuracy and safety of these procedures.
"We are looking forward to joining the outstanding
Spectrum-supported practices and the OCLI Vision team," noted R. J.
Mackool. "Over the years we have dedicated our practice to
providing the highest level of care to our patients. In joining
Spectrum Vision Partners, we expect to further enhance the care and
innovations we provide. Together with their team of eye care
experts and our experience, we foresee great opportunities to bring
new technologies and innovations to a broader stage."
The Bloom Organization, specialists in healthcare mergers and
acquisitions, assisted in the transaction with The Mackool Eye
Institute and Laser Center.
For more information about Spectrum Vision Partners, please
contact:
Tom Burke
Chief Executive Officer
tburke@spectrumvisionpartners.com
Greg Wappett
Chief Development Officer
gwappett@spectrumvisionpartners.com
About Mackool Eye Institute
Mackool Eye Institute (http://www.mackooleyesurgery.com) was
established in 1982 by Dr. Richard
Mackool, with the purpose of providing eye surgery and laser
treatment with minimal patient recovery times. The Mackool Eye
Institute and affiliates ("MEI") consists of an ophthalmology
ambulatory surgery center and ophthalmology practice located in
Astoria, NY.
About OCLI Vision
Founded in 1997, OCLI Vision (http://www.ocli.net) is one of the
leading ophthalmology practices in the
United States. The practices of OCLI Vision offer eye care
services at locations throughout Connecticut, New
Jersey, New York, and
Pennsylvania. OCLI Vision is led
by a large group of highly skilled ophthalmologists and
optometrists in each major sub-specialty of eye care who provide
comprehensive eye care services, including treatment for cataracts,
corneal disease, glaucoma, retinal disease, oculoplastics,
refractive surgery, and neuro-ophthalmology.
About Spectrum Vision Partners
Spectrum Vision Partners (SVP)
(http://www.spectrumvisionpartners.com) is a leading management
services organization, serving the ophthalmology sector. With over
1,200 employees providing world-class practice management and
administrative solutions to a network of nationally renowned,
multi-specialty ophthalmologists in New
York, New Jersey,
Connecticut and Pennsylvania, SVP supports over 40 clinic
locations, five state-licensed ambulatory surgery centers, and over
110 surgeons, doctors and other medical professionals. SVP provides
a comprehensive set of business support functions, including
billing and collections, credential services, marketing, physician
recruitment, ASC development, financial and accounting services,
benefits and payroll management and information technology. The
company's corporate service center is located at 825 East Gate
Boulevard, Suite 111, Garden City,
NY 11530.
About Blue Sea Capital
Blue Sea Capital (http://www.blueseacapital.com) is a private
equity firm based in West Palm Beach,
Florida, that invests in growth-oriented lower middle market
companies valued up to $250 million.
The firm has more than $750 million
in assets under management and invests across three industry
verticals: aerospace & defense, healthcare, and industrial
growth. Blue Sea Capital's strategy is to partner with talented
managers and differentiated companies, typically as the first or
second institutional investor, and deliver strategic and
operational value-add that drives growth acceleration, industry
outperformance and business transformation.
Media Contact
Peter Spanos, Spectrum Vision
Partners, 9174686637, pspanos@spectrumvisionpartners.com
SOURCE Spectrum Vision Partners